Article Details
Retrieved on: 2020-11-09 08:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>The University of Virginia Health is part of a national phase 3 clinical trial testing <b>monoclonal antibodies</b> made by the drug company Regeneron ...</div>
Article found on:
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here